Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB01590_nanopub.RACt00DqJWPcMpWmXVKMmoE0gbM6VxSaNXc35IZqLUcA8#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB01590 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01590 label "Everolimus [drugbank:DB01590]" assertion.
- drugbank:DB01590 seeAlso afinitor-drug.htm assertion.
- drugbank:DB01590 seeAlso everolimus.html assertion.
- drugbank:DB01590 seeAlso DB01590 assertion.
- drugbank:DB01590 description "Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 protein and not on the mTORC2 protein." assertion.
- drugbank:DB01590 identifier "drugbank:DB01590" assertion.
- drugbank:DB01590 title "Everolimus" assertion.
- drugbank:DB01590 drugbank_vocabulary:x-cas cas:159351-69-6 assertion.
- drugbank:DB01590 drugbank_vocabulary:drugbank-id "DB01590" assertion.
- drugbank:DB01590 bio2rdf_vocabulary:x-identifiers.org DB01590 assertion.
- drugbank:DB01590 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01590" assertion.
- drugbank:DB01590 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01590 bio2rdf_vocabulary:identifier "DB01590" assertion.
- drugbank:DB01590 drugbank_vocabulary:x-wikipedia wikipedia:Everolimus assertion.
- drugbank:DB01590 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164746311 assertion.
- drugbank:DB01590 drugbank_vocabulary:x-kegg kegg:D02714 assertion.
- drugbank:DB01590 drugbank_vocabulary:x-atc atc:L04AA18 assertion.
- drugbank:DB01590 drugbank_vocabulary:x-ndc ndc:0078-0417-20 assertion.